Stockreport

Virpax Announces Pricing of $2.25 Million Public Offering [Yahoo! Finance]

Virpax Pharmaceuticals, Inc.  (VRPX) 
PDF developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, announc [Read more]